Cargando…
In Vitro Synergism of Penicillin and Ceftriaxone against Enterococcus faecalis
Enterococcus faecalis infective endocarditis is commonly treated with intravenous ampicillin/ceftriaxone combination therapy. Ampicillin, however, is unsuitable for outpatient parenteral antibiotic therapy (OPAT) regimens due to its instability in 24 h continuous infusors, and has been successfully...
Autores principales: | Thieme, Lara, Briggs, Simon, Duffy, Eamon, Makarewicz, Oliwia, Pletz, Mathias W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541343/ https://www.ncbi.nlm.nih.gov/pubmed/34683470 http://dx.doi.org/10.3390/microorganisms9102150 |
Ejemplares similares
-
681. Penicillin Plus Ceftriaxone Against Enterococcus faecalis In Vitro Time-Kill Studies
por: Khan, Ruhmazia, et al.
Publicado: (2021) -
Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood Isolates
por: Cusumano, Jaclyn A., et al.
Publicado: (2022) -
1522. Penicillin plus ceftaroline against Enterococcus faecalis blood isolates lacking ampicillin plus ceftriaxone activity
por: Nwoye, Angella, et al.
Publicado: (2022) -
Ampicillin Plus Ceftriaxone Regimen against Enterococcus faecalis Endocarditis: A Literature Review
por: Marino, Andrea, et al.
Publicado: (2021) -
184. Implications of Enterococcus faecalis penicillin susceptibility in patients with bacteremia
por: Hedvat, Jason, et al.
Publicado: (2023)